Health Canada has authorized the use of a fifth COVID-19 vaccine to add to its arsenal and perhaps lead to an uptick in vaccinations among people who remain hesitant. The Nuvaxovid vaccine, which is protein-based, is the first of its kind to get approval in the country. "It can help remove barriers to vaccination by providing an additional option to adults who have not yet received a COVID-19 vaccine," Dr. Theresa Tam, Canada’s chief public health officer, said Thursday. Infectious disease docto
0コメント